Literature DB >> 19631468

Pain site frequency and location in sickle cell disease: the PiSCES project.

Donna K McClish1, Wally R Smith, Bassam A Dahman, James L Levenson, John D Roberts, Lynne T Penberthy, Imoigele P Aisiku, Susan D Roseff, Viktor E Bovbjerg.   

Abstract

Treatment options for sickle cell disease (SCD) pain could be tailored to pain locations. But few epidemiologic descriptions of SCD pain location exist; these are based on few subjects over short time periods. We examined whether SCD pain locations vary by disease genotype, gender, age, frequency of pain, depression, pain crisis or healthcare utilization. We enrolled 308 adults with SCD in 2002-2004. Subjects kept daily pain diaries for up to 6months, including a body chart. Mixed model and generalized estimating equations were employed for analyses. Two hundred and sixty subjects completed at least one body chart. An average of 3.3/16 sites (25%) were painful. The number of pain sites varied by age, depression, frequent pain days, crisis and unplanned hospital/ED utilization. Lower back, knee/shin and hip, hurt on average more than a third of pain days, while jaw and pelvis hurt on fewer than 10% of days. Odds of a crisis were increased substantially when pain was in the arm, shoulder, upper back, sternum, clavicle, chest or pelvis (OR>1.5) while the odds of unplanned utilization were substantially increased for the sternum, clavicle and chest (OR>2.0). Pain in SCD varies considerably both within and between subjects, although it occurs most commonly in the lower back and lower extremities. The number and location of pain sites vary significantly by age, frequent pain, crisis and utilization. Identification and understanding of combinations of pain location and intensity may help to understand the etiology of SCD and improve SCD management.

Entities:  

Mesh:

Year:  2009        PMID: 19631468      PMCID: PMC2771372          DOI: 10.1016/j.pain.2009.06.029

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  35 in total

Review 1.  Predicting clinical severity in sickle cell anaemia.

Authors:  M H Steinberg
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

2.  Understanding pain and improving management of sickle cell disease: the PiSCES study.

Authors:  Wally R Smith; Viktor E Bovbjerg; Lynne T Penberthy; Donna K McClish; James L Levenson; John D Roberts; Karen Gil; Susan D Roseff; Imoigele P Aisiku
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

3.  Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool.

Authors:  Linda S Franck; Marsha Treadwell; Eufemia Jacob; Elliott Vichinsky
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

4.  Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study.

Authors:  Graziano Onder; Francesco Landi; Giovanni Gambassi; Rosa Liperoti; Manuel Soldato; Chiara Catananti; Harriet Finne-Soveri; Cornelius Katona; Iain Carpenter; Roberto Bernabei
Journal:  J Clin Psychiatry       Date:  2005-08       Impact factor: 4.384

5.  Water sports and sickle cell anemia.

Authors:  S J Ratner; E A Athanasian
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

8.  Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project.

Authors:  Donna K McClish; James L Levenson; Lynne T Penberthy; Susan D Roseff; Viktor E Bovbjerg; John D Roberts; Imoigele P Aisiku; Wally R Smith
Journal:  J Womens Health (Larchmt)       Date:  2006-03       Impact factor: 2.681

Review 9.  The epidemiology of pain in depression.

Authors:  Jean-Pierre Lépine; Mike Briley
Journal:  Hum Psychopharmacol       Date:  2004-10       Impact factor: 1.672

10.  Follow-up of sickle cell disease patients with priapism treated by hydroxyurea.

Authors:  Sara T O Saad; Camila Lajolo; Simone Gilli; José Francisco C Marques Júnior; Carmen S Lima; Fernando F Costa; Valder R Arruda
Journal:  Am J Hematol       Date:  2004-09       Impact factor: 10.047

View more
  23 in total

1.  Increased clearance of morphine in sickle cell disease: implications for pain management.

Authors:  Deepika S Darbari; Michael Neely; John van den Anker; Sohail Rana
Journal:  J Pain       Date:  2011-02-01       Impact factor: 5.820

2.  Usability testing of a Smartphone for accessing a web-based e-diary for self-monitoring of pain and symptoms in sickle cell disease.

Authors:  Eufemia Jacob; Jennifer Stinson; Joana Duran; Ankur Gupta; Mario Gerla; Mary Ann Lewis; Lonnie Zeltzer
Journal:  J Pediatr Hematol Oncol       Date:  2012-07       Impact factor: 1.289

3.  Bayesian analyses demonstrate tissue blood volume is not decreased during acute sickle cell pain episodes: A preliminary study.

Authors:  Maria Perry; Jena Simon; Daniel Gareau; Jeffrey Glassberg
Journal:  Clin Hemorheol Microcirc       Date:  2016       Impact factor: 2.375

Review 4.  Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review.

Authors:  Joep W R Sins; David J Mager; Shyrin C A T Davis; Bart J Biemond; Karin Fijnvandraat
Journal:  Blood Adv       Date:  2017-08-22

Review 5.  Improving Emergency Department-Based Care of Sickle Cell Pain.

Authors:  Jeffrey A Glassberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.

Authors:  Marilyn J Telen; Araba Afenyi-Annan; Melanie E Garrett; Martha R Combs; Eugene P Orringer; Allison E Ashley-Koch
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

7.  SickleREMOTE: A Two-Way Text Messaging System for Pediatric Sickle Cell Disease Patients.

Authors:  Chihwen Cheng; Clark Brown; Tamara New; Todd H Stokes; Carlton Dampier; May D Wang
Journal:  IEEE EMBS Int Conf Biomed Health Inform       Date:  2012-06-08

8.  Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.

Authors:  Diana J Wilkie; Robert Molokie; Debra Boyd-Seal; Marie L Suarez; Young Ok Kim; Shiping Zong; Harriet Wittert; Zhongsheng Zhao; Yogen Saunthararajah; Zaijie J Wang
Journal:  J Natl Med Assoc       Date:  2010-01       Impact factor: 1.798

9.  A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients.

Authors:  Patrick C Carroll; Carlton Haywood; Michelle R Hoot; Sophie Lanzkron
Journal:  Clin J Pain       Date:  2013-04       Impact factor: 3.442

10.  High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study.

Authors:  Ifeyinwa Osunkwo; Thomas R Ziegler; Jessica Alvarez; Courtney McCracken; Korin Cherry; Chinyere E Osunkwo; Solomon F Ofori-Acquah; Samit Ghosh; Adeolu Ogunbobode; Jim Rhodes; James R Eckman; Carlton Dampier; Vin Tangpricha
Journal:  Br J Haematol       Date:  2012-08-28       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.